298 related articles for article (PubMed ID: 19558269)
1. Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
Mirzaei H; Akrami SM; Golmohammadi T; Doosti M; Heshmat R; Nakhjavani M; Amiri P
Metab Syndr Relat Disord; 2009 Oct; 7(5):453-8. PubMed ID: 19558269
[TBL] [Abstract][Full Text] [Related]
2. A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.
Danawati CW; Nagata M; Moriyama H; Hara K; Yasuda H; Nakayama M; Kotani R; Yamada K; Sakata M; Kurohara M; Wiyono P; Asdie H; Sakaue M; Taniguchi H; Yokono K
Diabetes Metab Res Rev; 2005; 21(5):465-9. PubMed ID: 15739197
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects.
Li LL; Ma XL; Ran JX; Sun XF; Xu LM; Ren J; Mao XM
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):187-91. PubMed ID: 17941898
[TBL] [Abstract][Full Text] [Related]
4. [Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes].
Dong CP; He L; Li JN; Ye F; He M; Wang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):447-51. PubMed ID: 18683148
[TBL] [Abstract][Full Text] [Related]
5. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
[TBL] [Abstract][Full Text] [Related]
6. Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
Stefański A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Moleda P; Pilarska K
J Hum Hypertens; 2006 Sep; 20(9):684-92. PubMed ID: 16625233
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
[TBL] [Abstract][Full Text] [Related]
8. Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes.
Mohamed MB; Mtiraoui N; Ezzidi I; Chaieb M; Mahjoub T; Almawi WY
J Endocrinol Invest; 2007 Dec; 30(11):937-43. PubMed ID: 18250615
[TBL] [Abstract][Full Text] [Related]
9. Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population.
Majid M; Masood A; Kadla SA; Hameed I; Ganai BA
Biochem Genet; 2017 Feb; 55(1):10-21. PubMed ID: 27567620
[TBL] [Abstract][Full Text] [Related]
10. The association between the Pro12Ala variant in the PPARγ2 gene and type 2 diabetes mellitus and obesity in a Chinese population.
Wang X; Liu J; Ouyang Y; Fang M; Gao H; Liu L
PLoS One; 2013; 8(8):e71985. PubMed ID: 23991018
[TBL] [Abstract][Full Text] [Related]
11. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
Ghoussaini M; Meyre D; Lobbens S; Charpentier G; Clément K; Charles MA; Tauber M; Weill J; Froguel P
BMC Med Genet; 2005 Mar; 6():11. PubMed ID: 15784141
[TBL] [Abstract][Full Text] [Related]
12. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian Indians.
Bhatt SP; Misra A; Sharma M; Luthra K; Guleria R; Pandey RM; Vikram NK
Diabetes Technol Ther; 2012 Sep; 14(9):828-34. PubMed ID: 22694222
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients.
Zouari Bouassida K; Chouchane L; Jellouli K; Chérif S; Haddad S; Gabbouj S; Danguir J
Diabetes Metab; 2005 Apr; 31(2):119-23. PubMed ID: 15959417
[TBL] [Abstract][Full Text] [Related]
14. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
15. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK
J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
Azab MM; Abdel-Azeez HA; Zanaty MF; El Alawi SM
Clin Lab; 2014; 60(5):743-9. PubMed ID: 24839816
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) Pro12Ala in the Iranian population: relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes.
Namvaran F; Azarpira N; Rahimi-Moghaddam P; Dabbaghmanesh MH
Eur J Pharmacol; 2011 Dec; 671(1-3):1-6. PubMed ID: 21968139
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.
Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Auwerx J; Deeb SS; Amouyel P
Int J Obes Relat Metab Disord; 2000 Feb; 24(2):195-9. PubMed ID: 10702770
[TBL] [Abstract][Full Text] [Related]
20. PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
Jermendy A; Körner A; Kovács M; Madácsy L; Cseh K
J Pediatr Endocrinol Metab; 2011; 24(1-2):55-9. PubMed ID: 21528816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
